Skip to main content
TipRanks
Go Ultimate75% OFF

John Chiplin Insider Profile

4 Followers

John Chiplin, Director at Cynata Therapeutics Limited, holds 200.00K shares in Cynata Therapeutics Limited (Ticker: CYYNF), holds 1.00M shares in AdAlta Ltd. (Ticker: AU:1AD), holds 2.00M shares in Scancell Holdings (Ticker: GB:SCLP).

John Chiplin's Trading History

CYYNF
Cynata Therapeutics Limited
May 07, 2019DirectorUninformative Sell51.00K$44.40K
1AD
AdAlta Ltd.
Nov 29, 2018DirectorInformative Buy56.74K―
SCLP
Scancell Holdings
Apr 18, 2018DirectorInformative Buy108.00K£1.62M

You May Also Like

John Chiplin insider profile FAQ

What is the percentage of profitable transactions made by John Chiplin?
The percentage of profitable transactions made by John Chiplin is 40%.
What is the average return per transaction made by John Chiplin?
The average return per transaction made by John Chiplin is -5.30%.
What stocks does John Chiplin hold?
John Chiplin holds: CYYNF, GB:SCLP, AU:1AD stocks.
What was John Chiplin’s latest transaction?
John Chiplin’s latest transaction was an Uninformative Sell of $51.00K.
What was John Chiplin's most profitable transaction?
John Chiplin’s most profitable transaction was an Informative Buy of CYYNF stock on May 17, 2017. The return on the trade was 87.60%.
What is John Chiplin's role in Cynata Therapeutics Limited?
John Chiplin's role in Cynata Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.